Liver Cancer Treatment

Study Reveals Biomarker Could Guide Liver Cancer Treatment Response To Immunotherapy

According to a preclinical study conducted by researchers at Weill Cornell Medicine, it may soon be possible to determine which individuals with hepatocellular carcinoma (HCC), a type of liver cancer, could benefit from immunotherapy. Published on October 17 in 'Molecular Cell', the study explores the roles of two proteins, p62...